In vivo and in vitro uptake of surfactant lipids by alveolar type II cells and macrophages

被引:28
作者
Poelma, DLH
Zimmermann, LJI
Scholten, HH
Lachmann, B
van Iwaarden, JF
机构
[1] Erasmus Univ, Pediat Lab, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Anesthesiol, NL-3000 DR Rotterdam, Netherlands
关键词
pneumocyte; lung; liposome; fluorescence;
D O I
10.1152/ajplung.00478.2001
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The uptake of fluorescent-labeled liposomes (with a surfactant-like composition) by alveolar macrophages and alveolar type II cells was studied using flow cytometry, in vivo by instillation of the labeled liposomes in the trachea of ventilated rats followed by isolation of the alveolar cells and determination of the cell-associated fluorescence, and in vitro by incubation of isolated alveolar cells with the fluorescent liposomes. The results show that the uptake of liposomes by the alveolar cells is time and concentration dependent. In vivo alveolar macrophages internalize more than three times as many liposomes as alveolar type II cells, whereas in vitro, the amount of internalized liposomes by these cells is approximately the same. In vitro, practically all the cells (70-75%) internalize liposomes, whereas in vivo only 30% of the alveolar type II cells ingest liposomes vs. 70% of the alveolar macrophages. These results indicate that in vivo, only a small subpopulation of alveolar type II cells is able to internalize surfactant liposomes.
引用
收藏
页码:L648 / L654
页数:7
相关论文
共 21 条
[1]  
CRAPO JD, 1978, LAB INVEST, V39, P640
[2]  
DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141
[3]   ALKALINE-PHOSPHATASE - A MARKER OF ALVEOLAR TYPE-II CELL-DIFFERENTIATION [J].
EDELSON, JD ;
SHANNON, JM ;
MASON, RJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (05) :1268-1275
[4]   Alveolar epithelial type II cell: defender of the alveolus revisited [J].
Fehrenbach, H .
RESPIRATORY RESEARCH, 2001, 2 (01) :33-52
[5]   Surfactant lipid uptake and metabolism by neonatal and adult type II pneumocytes [J].
Griese, M ;
Beck, J ;
Feuerhake, F .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 277 (05) :L901-L909
[6]   Smaller sized particles are preferentially taken up by alveolar type II pneumocytes [J].
Griese, M ;
Reinhardt, D .
JOURNAL OF DRUG TARGETING, 1998, 5 (06) :471-+
[7]   Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs [J].
Gurel, O ;
Ikegami, M ;
Chroneos, ZC ;
Jobe, AH .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 280 (06) :L1266-L1272
[8]   Effects of ventilation style on surfactant metabolism and treatment response in preterm lambs [J].
Ikegami, M ;
Wada, K ;
Emerson, GA ;
Rebello, CM ;
Hernandez, RE ;
Jobe, AH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (02) :638-644
[9]   Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells [J].
Leslie, CC ;
McCormickShannon, K ;
Shannon, JM ;
Garrick, B ;
Damm, D ;
Abraham, JA ;
Mason, RJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (04) :379-387
[10]   HEPATOCYTE GROWTH-FACTOR IS A GROWTH-FACTOR FOR RAT ALVEOLAR TYPE-II CELLS [J].
MASON, RJ ;
LESLIE, CC ;
MCCORMICKSHANNON, K ;
DETERDING, RR ;
NAKAMURA, T ;
RUBIN, JS ;
SHANNON, JM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (05) :561-567